128 related articles for article (PubMed ID: 17291487)
1. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
Ferrer B; Gorriti MA; Palomino A; Gornemann I; de Diego Y; Bermudez-Silva FJ; Bilbao A; Fernandez-Espejo E; Moratalla R; Navarro M; Rodríguez de Fonseca F
Eur J Pharmacol; 2007 Mar; 559(2-3):180-3. PubMed ID: 17291487
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
[TBL] [Abstract][Full Text] [Related]
3. Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex.
Zenko M; Zhu Y; Dremencov E; Ren W; Xu L; Zhang X
J Neurosci Res; 2011 Aug; 89(8):1245-58. PubMed ID: 21557291
[TBL] [Abstract][Full Text] [Related]
4. Nafadotride administration increases D1 and D1/D2 dopamine receptor mediated behaviors.
Dall'Olio R; Gaggi R; Voltattorni M; Tanda O; Gandolfi O
Behav Pharmacol; 2002 Dec; 13(8):633-8. PubMed ID: 12478213
[TBL] [Abstract][Full Text] [Related]
5. Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):194-204. PubMed ID: 10881041
[TBL] [Abstract][Full Text] [Related]
6. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.
Giuffrida A; Parsons LH; Kerr TM; Rodríguez de Fonseca F; Navarro M; Piomelli D
Nat Neurosci; 1999 Apr; 2(4):358-63. PubMed ID: 10204543
[TBL] [Abstract][Full Text] [Related]
7. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
8. A vehicle injection into the right core of the nucleus accumbens both reverses the region-specificity and alters the type of contralateral turning elicited by unilateral stimulation of dopamine D2/D3 and D1 receptors in the left core of the nucleus accumbens.
Ikeda H; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Dec; 577(1-3):64-70. PubMed ID: 17884038
[TBL] [Abstract][Full Text] [Related]
9. Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model.
El-Banoua F; Caraballo I; Flores JA; Galan-Rodriguez B; Fernandez-Espejo E
Neurobiol Dis; 2004 Jul; 16(2):377-85. PubMed ID: 15193294
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.
Rimondini R; Ferré S; Giménez-Llort L; Ogren SO; Fuxe K
Eur J Pharmacol; 1998 Apr; 347(2-3):153-8. PubMed ID: 9653875
[TBL] [Abstract][Full Text] [Related]
11. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
12. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
Wirtshafter D; Osborn CV
Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
[TBL] [Abstract][Full Text] [Related]
13. D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry.
O'Neill C; Evers-Donnelly A; Nicholson D; O'Boyle KM; O'Connor JJ
J Neurochem; 2009 Feb; 108(3):545-51. PubMed ID: 19187091
[TBL] [Abstract][Full Text] [Related]
14. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
Cauli O; Morelli M
Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
[TBL] [Abstract][Full Text] [Related]
15. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
16. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
Peng RY; Mansbach RS; Braff DL; Geyer MA
Neuropsychopharmacology; 1990 Jun; 3(3):211-8. PubMed ID: 2141986
[TBL] [Abstract][Full Text] [Related]
17. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
Synapse; 2008 May; 62(5):345-51. PubMed ID: 18297692
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
Zhou LW; Qin ZH; Weiss B
Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
[TBL] [Abstract][Full Text] [Related]
20. An automated method for the assessment of spontaneous and stereotyped climbing behavior in mice. Effects of the selective D1- and D2-dopamine receptor agonists SKF-38393 and RU-24926 and their association.
Simon P; Charpentier S; Costentin J
Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):99-104. PubMed ID: 1830125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
